Natural Killer Cells Therapeutics Market Trends, Demand, Competitive Outlook Forecast to 2021-2026
According to IMARC Group’s latest report, titled “Natural Killer Cells Therapeutics Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026”, The global natural killer cells therapeutics market exhibited strong growth during 2015-2020. Natural killer (NK) cells are large granular lymphocytes responsible for producing immunoregulatory cytokines. They are a type of white blood cells that act as a vital component of the human immune system. They contain small granules of special proteins such as proteases and perforin known as granzymes. NK cell therapeutics are developed through ex vivo pre-conditioning with cytokine or small molecular drugs and chimeric antigen receptor (CAR) NK. They aim at pathogenic antigens with cytotoxicity and reduce the risk of cytokine storms.
We are regularly tracking the direct effect of COVID-19
on the market, along with the indirect influence of associated industries.
These observations will be integrated into the report.
Request for a PDF sample of this report: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market/requestsample
The global NK
cells therapeutics market is primarily driven by their increasing utilization
in various molecular and combination therapies for various treatments. They are
used as effective therapeutic drugs in cases of cancer, liver and infectious
diseases. Furthermore, the rising awareness regarding the importance of
immunotherapies has increased the need for better therapeutic options and the
launch of new products, which is expected to influence market growth in the
future. As a result, several research activities have resulted in the
development of allogeneic NK cells with maximum therapeutic effects. They also
enhance the target and extend the persistence of potent immune cells, which
helps create a strong and sustained anti-cancer immune-mediated attack. Looking
forward, IMARC Group expects the market to grow at a CAGR of around 15% during
2021-2026.
Competitive
Landscape with Key Players:
·
Affimed GmbH
·
Bristol-Myers
Squibb Company
·
Fate
Therapeutics
·
Fortress
Biotech Inc.
·
Glycostem
Therapeutics
·
Innate Pharma
S.A.
·
Kuur
Therapeutics Inc
·
Athenex Inc
·
Nkarta Inc.
·
Takeda
Pharmaceutical Company Limited
·
Ziopharm
Oncology Inc.
Breakup by Therapeutics:
·
NK Cell
Therapies
·
NK Cell
Directed Antibodies
Breakup by Application:
·
Cancer
·
Gastrointestinal
Diseases
·
Immunoproliferative
Disorders
·
Others
Breakup by End User:
·
Hospitals
·
Research
Centers and Institutes
·
Others
Breakup by Region:
·
North America (United States, Canada)
·
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
·
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
·
Latin America (Brazil, Mexico, Others)
·
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq,
Others)
Ask
Analyst for Customization and Explore full report with TOC & List of Figures: https://bit.ly/3sSI5ih
We
are updating our reports, If you want latest primary and secondary data
(2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc.
Click request free sample report, published report will be delivered to you in
PDF format via email within 24 to 48 hours.
Key highlights
of the report:
- Market Performance (2015-2020)
- Market
Outlook (2021-2026)
- Market
Trends
- Market
Drivers and Success Factors
- The Impact
of COVID-19 on the Global Market
- Value Chain
Analysis
- Structure of
the Global Market
- Comprehensive
mapping of the competitive landscape
If you need specific information that is not
currently within the scope of the report, we will provide it to you as a part
of the customization.
IMARC
Group is a leading market research company that offers management strategy and
market research worldwide. We partner with clients in all sectors and regions
to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact
US:
IMARC
Group
30 N
Gould St Ste R
Sheridan,
WY 82801 USA - Wyoming
Email:
Sales@imarcgroup.com
Tel
No:(D) +91 120 433 0800
Americas:
- +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia:
+91-120-433-0800, +91-120-433-0800
Comments
Post a Comment